Minocycline treatment prevents cavitation in rats after a cortical devascularizing lesion

Brain Research

Volumn 1090, Issue 1, 2006, Pages 172-181

  Hua, Rui ^a   Walz, Wolfgang ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Astrocytes; Ischemia; Microglia; Minocycline; Reactive gliosis; Stroke

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; MINOCYCLINE; MYELOPEROXIDASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD VESSEL OCCLUSION; BRAIN BLOOD VESSEL; BRAIN INFARCTION; BRAIN INJURY; CONTROLLED STUDY; DEVASCULARIZATION; IMMUNOREACTIVITY; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MICROGLIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ASTROCYTES; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBRAL INFARCTION; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; INTERLEUKIN-1; LEUKOCYTES; MALE; MICROGLIA; MINOCYCLINE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; TREATMENT OUTCOME; UP-REGULATION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33744545439     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.03.072     Document Type: Article

References (48)

1. Arboix A., and Marti-Vilalta J.L. New concepts in lacunar stroke etiology: the constellation of small-vessel arterial disease. Cerebrovasc. Dis. 17 Suppl. 1 (2004) 58-62
2. Arvin K.L., Han B.H., Du Y., Lin S.Z., Paul S.M., and Holtzman D.M. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 52 (2002) 54-61
3. Bar, T., (1980). The vascular system of the cerebral cortex. Adv. Anat. Embryol. Cell Biol. 59, I-VI,1-62.
4. Boenisch T. Formalin-fixed and heat-retrieved tissue antigens: a comparison of their immunoreactivity in experimental antibody diluents. Appl. Immunohistochem. Mol. Morphol. 9 (2001) 176-179
5. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., and Yong V.W. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125 (2002) 1297-1308
6. Chen M., Ona V.O., Li M., Ferrante R.J., Fink K.B., Zhu S., Bian J., Guo L., Farrell L.A., Hersch S.M., Hobbs W., Vonsattel J.P., Cha J.H., and Friedlander R.M. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6 (2000) 797-801
7. Diguet E., Rouland R., and Tison F. Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease. Ann. Neurol. 54 (2003) 841-842
8. Diguet E., Fernagut P.O., Wei X., Du Y., Rouland R., Gross C., Bezard E., and Tison F. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur. J. Neurosci. 19 (2004) 3266-3276
9. Diguet E., Gross C.E., Tison F., and Bezard E. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Exp. Neurol. 189 (2004) 1-4
10. Domercq M., and Matute C. Neuroprotection by tetracyclines. Trends Pharmacol. Sci. 25 (2004) 609-612
11. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., Triarhou L.C., Chernet E., Perry K.W., Nelson D.L., Luecke S., Phebus L.A., Bymaster F.P., and Paul S.M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14669-14674
12. Fagan S.C., Edwards D.J., Borlongan C.V., Xu L., Arora A., Feuerstein G., and Hess D.C. Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp. Neurol. 186 (2004) 248-251
13. Fendrick S.E., Miller K.R., and Streit W.J. Minocycline does not inhibit microglia proliferation or neuronal regeneration in the facial nucleus following crush injury. Neurosci. Lett. 385 (2005) 220-223
14. Fisher C.M. Lacunar strokes and infarcts: a review. Neurology 32 (1982) 871-876
15. Fitch M.T., Doller C., Combs C.K., Landreth G.E., and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19 (1999) 8182-8198
16. Fox C., Dingman A., Derugin N., Wendland M.F., Manabat C., Ji S., Ferriero D.M., and Vexler Z.S. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 25 (2005) 1138-1149
17. Giulian D., Woodward J., Young D.G., Krebs J.F., and Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8 (1988) 2485-2490
18. Gotts J.E., and Chesselet M.F. Migration and fate of newly born cells after focal cortical ischemia in adult rats. J. Neurosci. Res. 80 (2005) 160-171
19. Herx L.M., and Yong V.W. Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J. Neuropathol. Exp. Neurol. 60 (2001) 961-971
20. Kato H., and Walz W. The initiation of the microglial response. Brain Pathol. 10 (2000) 137-143
21. Koistinaho M., Malm T.M., Kettunen M.I., Goldsteins G., Starckx S., Kauppinen R.A., Opdenakker G., and Koistinaho J. Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J. Cereb. Blood Flow Metab. 25 (2005) 460-467
22. Lee S.M., Yune T.Y., Kim S.J., Park Do W., Lee Y.K., Kim Y.C., Oh Y.J., Markelonis G.J., and Oh T.H. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J. Neurotrauma 20 (2003) 1017-1027
23. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568
24. Mergenthaler P., Dirnagl U., and Meisel A. Pathophysiology of stroke: lessons from animal models. Metab. Brain Dis. 19 (2004) 151-167
25. Muir K.W., and Grosset D.G. Neuroprotection for acute stroke: making clinical trials work. Stroke 30 (1999) 180-182
26. Pekny M., and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50 (2005) 427-434
27. Planas A.M., Justicia C., Sole S., Friguls B., Cervera A., Adell A., and Chamorro A. Certain forms of matrix metalloproteinase-9 accumulate in the extracellular space after microdialysis probe implantation and middle cerebral artery occlusion/reperfusion. J. Cereb. Blood Flow Metab. 22 (2002) 918-925
28. Sanchez Mejia R.O., Ona V.O., Li M., and Friedlander R.M. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48 (2001) 1393-1399 (discussion 1399-401)
29. Savchenko V.L., McKanna J.A., Nikonenko I.R., and Skibo G.G. Microglia and astrocytes in the adult rat brain: comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity. Neuroscience 96 (2000) 195-203
30. Smith D.L., Woodman B., Mahal A., Sathasivam K., Ghazi-Noori S., Lowden P.A., Bates G.P., and Hockly E. Minocycline and doxycycline are not beneficial in a model of Huntington's disease. Ann. Neurol. 54 (2003) 186-196
31. Stirling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., Ramer M.S., and Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24 (2004) 2182-2190
32. Streit W.J. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J. Histochem. Cytochem. 38 (1990) 1683-1686
33. Teng Y.D., Choi H., Onario R.C., Zhu S., Desilets F.C., Lan S., Woodard E.J., Snyder E.Y., Eichler M.E., and Friedlander R.M. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3071-3076
34. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., and Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21 (2001) 2580-2588
35. Tsuji M., Wilson M.A., Lange M.S., and Johnston M.V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp. Neurol. 189 (2004) 58-65
36. Wang K., and Walz W. Unusual topographical pattern of proximal astrogliosis around a cortical devascularizing lesion. J. Neurosci. Res. 73 (2003) 497-506
37. Wang X., Louden C., Yue T.L., Ellison J.A., Barone F.C., Solleveld H.A., and Feuerstein G.Z. Delayed expression of osteopontin after focal stroke in the rat. J. Neurosci. 18 (1998) 2075-2083
38. Wang X., Zhu S., Drozda M., Zhang W., Stavrovskaya I.G., Cattaneo E., Ferrante R.J., Kristal B.S., and Friedlander R.M. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10483-10487
39. Wang K., Bekar L.K., Furber K., and Walz W. Vimentin-expressing proximal reactive astrocytes correlate with migration rather than proliferation following focal brain injury. Brain Res. 1024 (2004) 193-202
40. Wells J.E., Hurlbert R.J., Fehlings M.G., and Yong V.W. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126 (2003) 1628-1637
41. Xu L., Fagan S.C., Waller J.L., Edwards D., Borlongan C.V., Zheng J., Hill W.D., Feuerstein G., and Hess D.C. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol. 4 (2004) 7
42. Yang L., Sugama S., Chirichigno J.W., Gregorio J., Lorenzl S., Shin D.H., Browne S.E., Shimizu Y., Joh T.H., Beal M.F., and Albers D.S. Minocycline enhances MPTP toxicity to dopaminergic neurons. J. Neurosci. Res. 74 (2003) 278-285
43. Yong V.W., Wells J., Giuliani F., Casha S., Power C., and Metz L.M. The promise of minocycline in neurology. Lancet Neurol. 3 (2004) 744-751
44. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., and Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15769-15774
45. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13496-13500
46. Zang da W., and Cheema S.S. Leukemia inhibitory factor promotes recovery of locomotor function following spinal cord injury in the mouse. J. Neurotrauma 20 (2003) 1215-1222
47. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu Du C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., and Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78
48. Ziaja M., and Janeczko K. Spatiotemporal patterns of microglial proliferation in rat brain injured at the postmitotic stage of postnatal development. J. Neurosci. Res. 58 (1999) 379-386